In last trading session, Biolife Solutions Inc (NASDAQ:BLFS) saw 0.38 million shares changing hands with its beta currently measuring 1.85. Company’s recent per share price level of $25.00 trading at -$0.06 or -0.24% at ring of the bell on the day assigns it a market valuation of $1.18B. That closing price of BLFS’s stock is at a discount of -18.2% from its 52-week high price of $29.55 and is indicating a premium of 40.64% from its 52-week low price of $14.84. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.45 million shares which gives us an average trading volume of 305.20K if we extend that period to 3-months.

For Biolife Solutions Inc (BLFS), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 4 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 4 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.04 in the current quarter.

Biolife Solutions Inc (NASDAQ:BLFS) trade information

Upright in the red during last session for losing -0.24%, in the last five days BLFS remained trading in the red while hitting it’s week-highest on Wednesday, 03/12/25 when the stock touched $25.00 price level, adding 7.58% to its value on the day. Biolife Solutions Inc’s shares saw a change of -3.70% in year-to-date performance and have moved -3.21% in past 5-day. Biolife Solutions Inc (NASDAQ:BLFS) showed a performance of -5.09% in past 30-days. Number of shares sold short was 3.4 million shares which calculate 12.21 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of 30 to the stock, which implies a rise of 16.67% to its current value. Analysts have been projecting 30 as a low price target for the stock while placing it at a high target of 30. It follows that stock’s current price would drop -20.0% in reaching the projected high whereas dropping to the targeted low would mean a loss of -20.0% for stock’s current value.

Biolife Solutions Inc (BLFS) estimates and forecasts

This year revenue growth is estimated to rise 17.96% from the last financial year’s standing.

9 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 22.22M for the same. And 9 analysts are in estimates of company making revenue of 23.46M in the next quarter. Company posted 31.73M and 28.33M of sales in current and next quarters respectively a year earlier.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -55.83% during past 5 years.

Biolife Solutions Inc (NASDAQ:BLFS)’s Major holders

Insiders are in possession of 1.85% of company’s total shares while institution are holding 101.52 percent of that, with stock having share float percentage of 103.43%. Investors also watch the number of corporate investors in a company very closely, which is 101.52% institutions for Biolife Solutions Inc that are currently holding shares of the company. CASDIN CAPITAL, LLC is the top institutional holder at BLFS for having 8.71 million shares of worth $186.59 million. And as of 2024-06-30, it was holding 18.927 of the company’s outstanding shares.

The second largest institutional holder is BLACKROCK INC., which was holding about 5.49 million shares on 2024-06-30. The number of shares represents firm’s hold over 12.0797 of outstanding shares, having a total worth of $117.61 million.

On the other hand, iShares Core S&P Smallcap ETF and Alger Small Cap Focus Fund are the top two Mutual Funds which own company’s shares. As of Jan 31, 2025 , the former fund manager was holding 2.33 shares of worth $58.2 million or 4.95% of the total outstanding shares. The later fund manager was in possession of 1.41 shares on Oct 31, 2024 , making its stake of worth around $35.37 million in the company or a holder of 3.01% of company’s stock.